INTS Intensity Therapeutics, Inc.
Fundamentals / CIK 0001567264 / USDIntensity Therapeutics, Inc. reported $10.29M in total assets and a net loss of $12.04M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$12.37M Operating profit
-
Net Income FY 2025-$12.04M GAAP bottom line
-
Diluted EPS FY 2025-$3.70 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$8.49M Total debt: $87K
Annual revenue and net income
4 fiscal years (2022 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Research & Development | $6.79M | $10.50M | $4.79M | $5.13M |
| Total Operating Expenses | $11.97M | $16.59M | $8.32M | $7.55M |
| Operating Income | -$11.97M | -$16.59M | -$8.32M | -$7.55M |
| Interest Income | $180K | $314K | $324K | $2.0K |
| Interest Expense | -- | $0 | $305K | $82K |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11.61M | -$16.27M | -$10.54M | -$7.58M |
| Basic EPS | -$8.56 | -$29.24 | -$34.50 | -$55.50 |
| Diluted EPS | -$8.56 | -$29.24 | -$34.50 | -$55.50 |
| Basic Shares Outstanding | 1.4M | 556.3K | 344.7K | 136.4K |
| Diluted Shares Outstanding | 1.4M | 556.3K | 344.7K | 136.4K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $2.43M | $1.83M | $1.20M | $1.50M | $1.55M | $1.54M | $2.19M | $1.97M |
| Total Operating Expenses | $3.62M | $3.08M | $2.53M | $3.14M | $2.73M | $2.71M | $3.39M | $3.20M |
| Operating Income | -$3.62M | -$3.08M | -$2.53M | -$3.14M | -$2.73M | -$2.71M | -$3.39M | -$3.20M |
| Interest Income | $82K | $77K | $94K | $88K | $59K | $17K | $15K | $28K |
| Net Income | -$3.54M | -$3.01M | -$2.43M | -$3.05M | -$2.67M | -$2.54M | -$3.35M | -$3.18M |
| Basic EPS | -$1.09 | -$1.11 | -$0.96 | -- | -$1.55 | -$3.36 | -$5.51 | -- |
| Diluted EPS | -$1.09 | -$1.11 | -$0.96 | -- | -$1.55 | -$3.36 | -$5.51 | -- |
| Basic Shares Outstanding | 3.3M | 2.7M | 2.5M | -- | 1.7M | 754.7K | 606.9K | -- |
| Diluted Shares Outstanding | 3.3M | 2.7M | 2.5M | -- | 1.7M | 754.7K | 606.9K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $11.92M | $2.59M | $8.56M | $1.31M |
| Cash & Short-Term Investments | $11.90M | $2.60M | $14.80M | $1.31M |
| Other Current Assets | -- | -- | $6.0K | $76K |
| Total Current Assets | $12.71M | $3.36M | $15.46M | $1.45M |
| Other Non-Current Assets | $1.30M | $1.30M | $1.68M | $167K |
| Total Non-Current Assets | $1.39M | $1.42M | $1.83M | $306K |
| Total Assets | $14.10M | $4.78M | $17.30M | $1.76M |
| Accounts Payable | $583K | $1.22M | $3.05M | $603K |
| Total Current Liabilities | $2.15M | $1.75M | $3.96M | $6.82M |
| Other Non-Current Liabilities | -- | $0 | $36K | $36K |
| Total Non-Current Liabilities | $79K | $110K | $174K | $36K |
| Total Liabilities | $2.23M | $1.86M | $4.13M | $6.86M |
| Total Debt (incl. Leases) | $110K | $138K | $158K | $143K |
| Common Stock | $0 | $0 | $1.0K | $0 |
| Retained Earnings | -$78.39M | -$66.78M | -$50.52M | -$38.65M |
| Total Stockholders' Equity | $11.88M | $2.92M | $13.16M | -$15.10M |
| Total Equity | $11.88M | $2.92M | $13.16M | -$15.10M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.49M | $9.53M | $10.24M | $11.92M | $7.07M | $2.22M | $929K | $2.59M |
| Cash & Short-Term Investments | $8.50M | $9.50M | $10.20M | $11.90M | $7.10M | $2.20M | $900K | $2.60M |
| Accounts Receivable, Net | $41K | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $9.50M | $11.23M | $10.91M | $12.71M | $8.19M | $3.04M | $1.65M | $3.36M |
| Other Non-Current Assets | $710K | $210K | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M |
| Total Non-Current Assets | $785K | $292K | $1.39M | $1.39M | $1.40M | $1.41M | $1.41M | $1.42M |
| Total Assets | $10.29M | $11.52M | $12.29M | $14.10M | $9.59M | $4.44M | $3.06M | $4.78M |
| Accounts Payable | $1.65M | $1.01M | $636K | $583K | $1.68M | $1.19M | $1.59M | $1.22M |
| Total Current Liabilities | $2.58M | $2.25M | $2.24M | $2.15M | $2.28M | $2.16M | $2.63M | $1.75M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $53K | $62K | $70K | $79K | $87K | $95K | $102K | $110K |
| Total Liabilities | $2.63M | $2.31M | $2.31M | $2.23M | $2.36M | $2.26M | $2.73M | $1.86M |
| Total Debt (incl. Leases) | $87K | $95K | $102K | $110K | $118K | $125K | $131K | $138K |
| Common Stock | $0 | $0 | $0 | $0 | $5.0K | $3.0K | $2.0K | $0 |
| Retained Earnings | -$87.37M | -$83.83M | -$80.82M | -$78.39M | -$75.34M | -$72.67M | -$70.13M | -$66.78M |
| Total Stockholders' Equity | $7.65M | $9.21M | $9.98M | $11.88M | $7.22M | $2.18M | $334K | $2.92M |
| Total Equity | $7.65M | $9.21M | $9.98M | $11.88M | $7.22M | $2.18M | $334K | $2.92M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -$11.61M | -$16.27M | -$10.54M | -$7.58M |
| Stock-Based Compensation | $2.00M | $3.07M | $1.40M | $1.17M |
| Operating Cash Flow | -$9.23M | -$15.22M | -$7.21M | -$5.48M |
| Purchases of Investments | $0 | -$3.06M | -$15.05M | $0 |
| Investing Cash Flow | $0 | $6.35M | -$6.02M | $0 |
| Financing Cash Flow | $18.56M | $2.90M | $20.47M | $2.25M |
| Net Change in Cash | $9.33M | -$5.97M | $7.24M | -$3.23M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.54M | -$3.01M | -$2.43M | -$3.05M | -$2.67M | -$2.54M | -$3.35M | -$3.18M |
| Stock-Based Compensation | $517K | $387K | $387K | $450K | $471K | $644K | $435K | $844K |
| Operating Cash Flow | -$2.50M | -$2.34M | -$1.83M | -$2.40M | -$2.39M | -$2.46M | -$1.99M | -$2.67M |
| Investing Cash Flow | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $345K | -- |
| Financing Cash Flow | $1.47M | $1.62M | $150K | $7.25M | $7.24M | $3.74M | $328K | $2.48M |
| Net Change in Cash | -$1.03M | -$716K | -$1.68M | $4.85M | $4.85M | $1.29M | -$1.66M | -$192K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Return on Equity (ROE) | -97.7% | -557.5% | -80.1% | -- |
| Return on Assets (ROA) | -82.3% | -340.1% | -60.9% | -431.5% |
| Current Ratio | 5.92x | 1.92x | 3.91x | 0.21x |
| Quick Ratio | 5.55x | 1.48x | 3.74x | 0.19x |
| Debt to Equity | 0.01x | 0.05x | 0.01x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -157.3% | -121.2% | -107.2% | -97.7% | -162.5% | -575.9% | -4494.6% | -557.5% |
| Return on Assets (ROA) | -117.0% | -96.9% | -87.0% | -82.3% | -122.4% | -283.1% | -489.8% | -340.1% |
| Current Ratio | 3.68x | 5.00x | 4.86x | 5.92x | 3.60x | 1.40x | 0.63x | 1.92x |
| Quick Ratio | 3.31x | 4.23x | 4.55x | 5.55x | 3.12x | 1.02x | 0.34x | 1.48x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.06x | 0.39x | 0.05x |